The forecasted performance of transluminal coronary angioplasties as day cases in the UK from 2024 to 2028 indicates a consistent decline. Starting from 14 cases in 2024, the number reduces sharply to 3.8 cases by 2028. Compared to 2023 figures, this represents a notable year-on-year percentage decrease of 20.7% for 2025, 24.3% for 2026, 28.6% for 2027, and 36.7% for 2028. The compound annual growth rate (CAGR) over this period suggests a continuing downward trajectory at an average yearly rate of decline.
Future trends to look for include advancements in non-invasive procedures, potential shifts toward other treatment methods, and technological innovations potentially impacting the need for angioplasties.
